Inloggad som:

CERTIS-1

Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.

CERTIS-1
A Modular Phase I/IIa, Open-label, Multi-centre Study to Assess the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of Ascending Doses of AZD9574 as Monotherapy and in Combination with Anti-cancer Agents in Patients with Advanced Solid Malignancies (CERTIS1)
A Modular Phase I/IIa, Open-label, Multi-centre Study to Assess the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of Ascending Doses of AZD9574 as Monotherapy and in Combination with Anti-cancer Agents in Patients with Advanced Solid Malignancies (CERTIS1)
PLACEHOLDER
Mer information om studien för vårdgivare
Behandling
Fas 1
Palliativ
Företag

Studien ändrades senast av: studyjohanna (2023-03-19)

Tillbaka till listan